TWD 17.5
(-0.57%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 157.72 Million TWD | -6.82% |
2022 | 169.26 Million TWD | 15.63% |
2021 | 146.38 Million TWD | 6.53% |
2020 | 137.41 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 41.19 Million TWD | 0.0% |
2024 Q1 | 41.19 Million TWD | 3.56% |
2023 Q4 | 39.78 Million TWD | 0.0% |
2023 FY | 157.72 Million TWD | -6.82% |
2023 Q3 | 39.78 Million TWD | 1.79% |
2023 Q2 | 39.08 Million TWD | 0.0% |
2023 Q1 | 39.08 Million TWD | -13.4% |
2022 FY | 169.26 Million TWD | 15.63% |
2022 Q4 | 45.12 Million TWD | 0.0% |
2021 FY | 146.38 Million TWD | 6.53% |
2020 FY | 137.41 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
GeneFerm Biotechnology Co., Ltd. | 132.78 Million TWD | -18.781% |
Easywell Biomedicals, Inc. | 333.45 Million TWD | 52.7% |
TTY Biopharm Company Limited | 1.91 Billion TWD | 91.749% |
Synmosa Biopharma Corporation | 1.49 Billion TWD | 89.482% |
Orient EuroPharma Co., Ltd. | 2.14 Billion TWD | 92.654% |
Center Laboratories, Inc. | 697.35 Million TWD | 77.383% |
Tien Liang BioTech Co., Ltd. | 267.27 Million TWD | 40.988% |
Orient Pharma Co., Ltd. | 468.66 Million TWD | 66.346% |
InnoPharmax Inc. | 82.29 Million TWD | -91.656% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 244.63 Million TWD | 35.526% |
Excelsior Biopharma Inc. | 388.05 Million TWD | 59.355% |
DV Biomed Co., Ltd. | 575.24 Million TWD | 72.581% |
Foresee Pharmaceuticals Co., Ltd. | 1.12 Billion TWD | 85.937% |
Handa Pharmaceuticals, Inc. | 399.14 Million TWD | 60.485% |
UniPharma Co., Ltd. | 78.32 Million TWD | -101.383% |
Anxo Pharmaceutical Co., Ltd. | 396.93 Million TWD | 60.264% |
Alar Pharmaceuticals Inc. | 83.74 Million TWD | -88.34% |
Winston Medical Supply Co., Ltd. | 151.49 Million TWD | -4.111% |
Mercury Biopharmaceutical Corporation | 592 Thousand TWD | -26542.736% |
Bioray Biotech Co., Ltd | 96.98 Million TWD | -62.633% |
TSH Biopharm Corporation Limited | 336.26 Million TWD | 53.096% |